ETF PRO AINovember 17, 2026
PPH VanEck Pharmaceutical ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.36%expense ratio
$1.1Bfund assets
+17.9%return, YTD
—return, 1 year
−$116Mnet flow, 1 month
−$250Mnet flow, 1 year
18.8%realized volatility, 1y
-11.5%worst drawdown, 1y
Top ten holdings
| 1 | LLY ELI LILLY | 23.05% |
| 2 | MRK MERCK & CO | 12.09% |
| 3 | NVO NOVO NORDISK A S | 5.49% |
| 4 | MCK MCKESSON | 5.00% |
| 5 | PFE PFIZER | 4.67% |
| 6 | TEVA TEVA PHARMACEUTICAL | 4.77% |
| 7 | COR CENCORA INC | 4.49% |
| 8 | BMY BRISTOL MYERS SQUIBB | 4.42% |
| 9 | GSK GSK | 4.19% |
| 10 | ABBV ABBVIE | 3.65% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS